Evidence map›Paper›PMID 32140799›Full record

ArticleAngiogenesis2020

Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice.

Yohei Tomita, Bertan Cakir, Chi-Hsiu Liu, Zhongjie Fu, Shuo Huang, Steve S Cho, William R Britton, Ye Sun, Mark Puder, Ann Hellström and 2 more

Open access · greenAbstract read
In one paragraph

Article in Angiogenesis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis.Journal of visualized experiments : JoVE · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yohei TomitaDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Bertan CakirDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Chi-Hsiu LiuDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Zhongjie FuDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Shuo HuangDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Steve S ChoDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
William R BrittonDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Ye SunDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA.
Mark PuderVascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, USA.
Ann HellströmPediatric Ophthalmology, Sahlgrenska Academy, The Queen Silvia Children's Hospital, Göteborg, Sweden.
Saswata TalukdarMerck & Co., Inc., South San Francisco, CA, USA.
Lois E H SmithDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA, 02115, USA. Lois.Smith@childrens.harvard.edu.ORCID 0000-0003-1013-5737
Boston Children's Hospital · USBoston University · USDrottning Silvias barn- och ungdomssjukhus · SEMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Dietary control of angiogenesis in retinopathy modelsR01EY017017 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Zhongjie Fu, Lois Smith · 2006 to 2026
$11.8M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI WOOLF, CLIFFORD J · 2016 to 2020
$5.2M
Photoreceptor Determination of Retinal Blood Vessel Growth in RetinopathyR01EY029238 · NEI · BOSTON CHILDREN'S HOSPITAL · PI YE SUN · 2019 to 2026
$2.6M
The Mechanism of Immune-Vascular Crosstalk in RetinopathyR01EY030140 · NEI · BOSTON CHILDREN'S HOSPITAL · PI SUN, YE · 2019 to 2023
$2.0M
Glucose/lipid metabolism and vessel development in phase I ROPR01EY030904 · NEI · BOSTON CHILDREN'S HOSPITAL · PI SMITH, LOIS · 2020 to 2023
$1.7M
NEI NIH HHS R01 EY017017NEI NIH HHS R01 EY029238NEI NIH HHS R01EY029238NEI NIH HHS R01 EY030140NEI NIH HHS R01EY030140NEI NIH HHS R01 EY030904NICHD NIH HHS U54 HD090255NIH HHS R01EY01717-13S1NIH HHS R24EY024868
6 · The paper itself

Abstract

To examine whether free fatty acid receptor 4 (FFAR4) activation can protect against choroidal neovascularization (CNV), which is a common cause of blindness, and to elucidate the mechanism underlying the inhibition, we used the mouse model of laser-induced CNV to mimic angiogenic aspects of age-related macular degeneration (AMD). Laser-induced CNV was compared between groups treated with an FFAR4 agonist or vehicle, and between FFAR4 wild-type (Ffar4

Indexed as

AnimalsChoroidal NeovascularizationCytokinesMaleMiceMice, KnockoutNF-kappa BReceptors, G-Protein-CoupledCytokinesFFAR4 protein, mouseNF-kappa BReceptors, G-Protein-CoupledAge-related macular degeneration (AMD)Free fatty acid receptor 4 (FFAR4)IL-6Laser-induced choroidal neovascularization (CNV)NF-ĸb

Identifiers

PMID32140799
PMCPMC8627650
OpenAlexW3009385327

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.